2. Society of Thoracic Surgeons Research Center, Chicago, Illinois
3. Department of Cardiothoracic Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands
4. Department of Cardiovascular Surgery, Mount Sinai Heart at Mount Sinai Saint Luke's, New York, New York
5. Department of Cardiac Surgery, John Radcliffe Hospital, Oxford, UK
6. Clinical Trials Centre, Cardiovascular Research Foundation, New York, New York; Center for Interventional Vascular Therapy, Division of Cardiology, New York-Presbyterian Hospital/Columbia University Medical Centre, New York, New York
7. Clinical Trials Centre, Cardiovascular Research Foundation, New York, New York
8. Imperial College of Science, Technology and Medicine, London, UK
9. Department of Surgery, University Hospitals Cleveland Medical Centre, Cleveland, Ohio
10. Department of Cardiothoracic Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands
As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers.
Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.
To read the full content of this article, please download the PDF. Download full article (PDF)
Methods and results: The predictive performance of STS risk models for perioperative mortality, stroke and renal failure were evaluated for their discriminative ability (C statistic) and calibration (Hosmer-Lemeshow goodness-of-fit-test; χ2 and p-values) among patients with LMCAD undergoing PCI-EES (n=935) and CABG (n=923) from the randomized EXCEL trial. STS risk scores, in CABG patients, showed good discrimination for 30-day mortality and average discrimination for stroke (C statistics 0.730 and 0.629 respectively) with average calibration. For PCI, STS risk scores had no discrimination for mortality (C statistic 0.507), yet good discrimination (C statistic 0.751) and calibration for stroke. The predictive performance for renal failure was good for CABG (C statistic 0.82), yet poor for PCI (C statistic 0.59).
Conclusions: In selected patients with LMCAD from the EXCEL trial, STS risk models showed good predictive performance for CABG yet lacked predictive performance for PCI for perioperative mortality and renal failure. The STS stroke risk model was surprisingly more discriminating in PCI compared to CABG EXCEL patients. Improved and procedure-specific risk-prediction instruments are needed to accurately estimate adverse events after LMCAD revascularization by CABG and PCI.
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com